FDA Recall Terminated

AlignRT- Intended for prescription use. The system is indicated for use during simulation, setup and stereotactic radiosurgery and precision radiotherapy for lesions, tumors and conditions anywhere in the body where radiation is indicated.

Recall: Z-0464-2015 · Initiated October 15, 2014

Recall

Recall Number
Z-0464-2015
Event Number
69515
Firm
Vision Rt Inc
FEI Number
3017888782
Product Code
IYE
Status
Terminated
Root Cause
Software in the Use Environment
Initiated
October 15, 2014
Posted
December 16, 2014
Terminated
May 10, 2016
Address
8840 Stanford Blvd, Columbia, MD, 21045-5827

Description

AlignRT- Intended for prescription use. The system is indicated for use during simulation, setup and stereotactic radiosurgery and precision radiotherapy for lesions, tumors and conditions anywhere in the body where radiation is indicated.

Reason

Potential failure of AlignRT to assert interlock.

Action

The firm, visionrt. sent an "URGENT MEDICAL DEVICE CORRECTION NOTIFICATION-URGENT FIELD SAFETY NOTICE" dated October 15, 2014 to all affected customers on 21-Oct-2014. The notice describes the product, problem and actions to be taken. The customers were informed that they did not need to return their devices; they should pass the letter to all those who need to be aware of it within their organization; promptly inform Vision RT if they believe that patient harm occurred due this issue, and complete and return the acknowledgement form via email to [email protected]. Vision RT is designing an upgrade that will resolve the issue, and will subsequently contact the customer in order to install the upgrade on their device. Should you have any queries on this letter, please do not hesitate to contact Vision RT by telephone on +44 20 83464300 (866 778-2379 from the US) or as per http://www.visionrt.com/contact/details.

Distribution

Worldwide Distribution: US distribution in states of: CA, MN, TX, and UT; and internationally to: Republic of Ireland.

Quantity

7 (Six Units distribited in the US and One in OUS.)